3218 Organometallics, Vol. 18, No. 16, 1999
Sato et al.
(η-C5Me5), 12.79 (Me), 13.25 (Me), 29.64 (m, CH2), 72.41 (η-
C5H5 in Rc), 81.03 (ipso-C), 83.90 (R-C), 86.15 (â-C), 92.60 (η-
C5Me5), 102.78 (Ct), 119.92 (t, 2J CP ) 25.9 Hz, RuCt), 127.48
CDCl3): δ 86.48. Anal. Calcd for C47H40P2Ru2‚1/2CH3OH: C,
64.47; H, 4.78. Found: C, 64.32; H, 4.83.
(η-C5Me5)Ru (µ-η5,η1-C5H4CtC)Ru (P P h 3)2(η5-C9H7) (15).
This complex was prepared from 1-ethynyl-1′,2′,3′,4′,5′-pen-
tamethylruthenocene and RuCl(PPh3)2(η5-C9H7) according to
the procedure used in preparing 9 and purified by recrystal-
lization from CH2Cl2-MeOH, to give red-orange crystals (60%).
Mp ∼195 °C dec. IR (KBr): 2088 cm-1 (ν(CtC)). 1H NMR
(CDCl3, 400 MHz): δ 2.08 (s, 15H, CH3), 4.02 (s, 4H, η-C5H4),
4.51 (d, J ) 2.7 Hz, 2H, 1-C9H7), 5.41 (t, J ) 2.7 Hz, 1H,
2-C9H7), 6.67 (A2B2 type, 2H, 5-C9H7), 6.74 (A2B2 type, 2H,
4-C9H7), and 7.03-7.26 (m, 30H, Ph). 13C NMR (C6D6, 100
MHz): δ 12.30 (C5Me5), 71.12 (η-C5H4), 74.86 (η-C5H4), 74.78
(1-C9H7), 79.82 (ipso-C5H4), 84.53 (C5Me5), 95.40 (2-C9H7),
3
(t, J CP ) 4.5 Hz, m-Ph), 128.67 (p-Ph), 129.21 (p-Ph), 133.53
2
2
(t, J CP ) 5.1 Hz), 134.73 (t, J CP ) 4.6 Hz), 138.15 (dd, J )
44.0 and 3.0 Hz, ipso-Ph) and 139.75 (dd, J ) 36.4 and 3.0
Hz, ipso-Ph). 31P NMR (162 MHz, CD2Cl2): δ 81.61. Anal.Calcd
for C52H56P2Ru2: C, 66.09; H, 5.97. Found: C, 66.05; H, 5.97.
(η-C5H5)Ru (µ-η5:η1-C5Me4CtC)Ru (d p p e)(η5-C9H7) (12).
To a solution of AgBF4 (21 mg, 0.11 mmol) in anhydrous
acetone (10 mL) was added RuCl(dppe)(η5-C9H7) (59 mg, 0.09
mmol) under nitrogen bubbling, and then the solution was
stirred for 3 min at room temperature. To the resulting deep
green mixture was added 4 (28 mg, 0.09 mmol) under an
atmosphere of nitrogen at room temperature. The solution was
stirred for 10 min. After evaporation of the solvent under
reduced pressure, the resulting brown residue was chromato-
graphed on Al2O3 deactivated with 5% H2O by elution with
CH2Cl2. The title complex was obtained as orange-yellow
crystals (56 mg, 67%). Mp: 222 °C dec. IR (KBr): 2089 cm-1
(ν(CtC)). 1H NMR (C6D6, 400 MHz): δ 1.79,(s, 6H, CH3), 1.91
(s, 6H, CH3), 2.12 (m, 2H, CH2), 2.64 (m, 2H, CH2), 4.03 (s,
5H, η-C5H5), 4.88 (t, J ) 2.5 Hz, 1H, 2-C9H7), 4.88 (d, J ) 2.5
Hz, 1H, 1-C9H7), and 6.96-7.64 (m, 24H, Ph + 4,5-C9H7). 13C
NMR (C6D6, 100 MHz): δ 12.72 (CH3), 13.12 (CH3), 28.58 (t,
J ) 23.1 Hz, CH2), 70.18 (1-C9H7), 72.42 (Cp), 79.87 (ipso-C5-
Me4), 83.80 (C5Me4), 86.01 (C5Me4), 92.62 (2-C9H7), 105.21
2
101.31 (t, J CP ) 25.7 Hz, RuCt), 106.54 (Ct), 109.33 (ipso-
C9H7), 123.16 (4 or 5-C9H7), 125.69 (4 or 5-C9H7), 127.25 (t,
2
3J CP ) 4.5 Hz, m-Ph), 128.54 (p-Ph), 134.60 (t, J CP ) 4.9 Hz,
o-Ph), and 138.72 (m, ipso-Ph). 31P NMR (162 MHz, CDCl3):
δ 50.49. Anal. Calcd for C62H56P2Ru2: C, 69.91; H, 5.30.
Found: C, 69.84; H, 5.26.
(η-C5Me5)Ru (µ-η5:η1-C5H4CtC)Ru (d p p e)(η5-C9H7) (16).
This complex was prepared from 1-ethynyl-1′,2′,3′,4′,5′-pen-
tamethylruthenocene and RuCl(dppe)(η5-C9H7) according to
the procedure described for 12 and purified by recrystallization
from CH2Cl2-MeOH. The title complex was obtained as red-
orange crystals (48%). Mp: ∼170 °C dec. IR (KBr): 2079 cm-1
(ν(CtC)). 1H NMR (C6D6, 400 MHz): δ 1.82 (m, 2H, CH2), 2.00
(s, 15H, η-C5Me5), 2.40 (m, 2H, CH2), 3.82 (t, J ) 1.6 Hz,
â-C5H4), 4.02 (t, J ) 1.6 Hz, R-C5H4), 5.08 (d, J ) 2.6 Hz, 2H,
1-C9H7), 5.25 (t, J ) 2.6 Hz, 1H, 2-C9H7), 6.87 (A2B2 type, 2H,
4- or 5-C9H7), 7.10 (A2B2 type, 2H, 4- or 5-C9H7), and 7.00-
7.62 (m, 20H, Ph). 13C NMR (C6D6, 100 MHz): δ 12.08
(η-C5Me5), 28.21 (t, J ) 23.3 Hz, CH2), 70.16 (1-C9H7), 70.75
(η-C5H4), 75.10 (η-C5H4), 79.70 (ipso-C5H4), 84.30 (η-C5Me5),
2
(Ct), 107.23 (t, J CP ) 25.0 Hz, RuCt), 108.48 (ipso-C9H7),
3
123.91 (4 or 5-C9H7), 124.67 (4 or 5-C9H7), 127.90 (t, J CP
)
)
2
3.7 Hz, m-Ph), 128.71 (p-Ph), 129.71 (p-Ph), 131.75 (t, J CP
2
5.0 Hz, o-Ph), 135.18 (t, J CP ) 5.2 Hz, o-Ph), 136.33 (m, ipso-
Ph), and 143.04 (m, ipso-Ph). 31P NMR (162 MHz, CDCl3): δ
89.08. Anal. Calcd for C51H48P2Ru2‚CH3OH: C, 65.26; H, 5.48.
Found: C, 65.45; H, 5.18.
2
(η-C5H 5)R u (µ-η5,η1-C5H 4CtC)R u (P P h 3)2(η5-C9H 7) (13).
This complex was prepared from ethynylruthenocene and
RuCl(PPh3)2(η5-C9H7) according to the procedure described for
complex 7 and purified by recrystallization from benzene-
pentane, to give red crystals (82%). Mp; 165 °C dec. IR (KBr):
2086 cm-1 (ν(CtC)). 1H NMR (CDCl3, 400 MHz): δ 4.16 (s,
5H, Cp), 4.38 (t, J ) 1.6 Hz, 2H, C5H4), 4.49 (d, J ) 2.5 Hz,
2H, 1-C9H7), 4.57 (t, J ) 1.6 Hz, 2H, C5H4), 5.35 (t, J ) 2.5
Hz, 1H, 2-C9H7), 6.10 (dd, J ) 3.0 and 6.3 Hz, 2H, 5-C9H7),
6.68 (dd, J ) 3.0 and 6.3 Hz, 2H, 4-C9H7), and 7.00-7.35 (m,
30H, Ph). 13C NMR (C6D6, 100 MHz): δ 68.74 (C5H4), 71.02
(Cp), 73.10 (C5H4), 74.80 (1-C9H7), 80.7 (ipso-C5H4), 95.49 (2-
92.62 (2-C9H7), 104.16 (Ct), 103.83 (t, J CP ) 25.5 Hz, RuCt
), 107.89 (ipso-C9H7), 123.74 (4 or 5-C9H7), 124.24 (4 or 5-C9H7),
3
127.52 (t, J CP ) 5.0 Hz, m-Ph), 128.88 (p-Ph), 129.36 (p-Ph),
132.26 (t, 2J CP ) 5.0 Hz, o-Ph), 134.48 (t, 2J CP ) 5.0 Hz, o-Ph),
137.11 (m, ipso-Ph), and 141.85 (m, ipso-Ph). 31P NMR (162
MHz, CDCl3): δ 87.52. Anal. Calcd for C52H50P2Ru2: C, 66.51;
H, 5.37. Found: C, 66.12; H, 5.31.
[(η-C5H5)Ru(µ-η6:η1-C5Me4CdCd)Ru(P P h3)2(η-C5H5)](BF4)2
(17). A solution of complex 7 (30 mg, 0.03 mmol) and p-
benzoquinone (5.5 mg, 0.05 mmol) in CH2Cl2 (3 mL) was chilled
below -80 °C. To the solution was added BF3‚OEt2 (0.1 mL).
The color of the solution turned orange to deep green and then
to reddish brown as the reaction temperature rose. At -40
°C, anhydrous diethyl ether (4 mL) was added, and then the
mixture was allowed to warm to room temperature. The upper
solution was removed by syringe, and the oily crystals remain-
ing were washed with diethyl ether. The residues were
dissolved in dry CH2Cl2 (8 mL). The solution was diluted with
diethyl ether (8 mL) and then kept in a freezer. The title
complex was obtained as dark brown needles (28 mg, 79%).
2
C9H7), 102.80 (t, J CP ) 25.6 Hz, RuCt), 106.55 (Ct), 109.34
(ipso-C9H7), 122.99 (4 or 5-C9H7), 125.90 (4 or 5-C9H7), 127.36
3
2
(t, J CP ) 4.5 Hz, m-Ph), 128.60 (p-Ph), 134.61 (t, J CP ) 4.8
Hz, o-Ph), and 138.74 (m, ipso-Ph). 31P NMR (162 MHz, CD2-
Cl2): δ 51.34. Anal. Calcd for C57H46P2Ru2‚2C6H6: C, 71.98;
H, 5.08. Found: C, 71.64; H, 5.05.
(η-C5H5)Ru (µ-η5:η1-C5H4CtC)Ru (dppe)(η5-C9H7) (14). This
complex was prepared from ethynylruthenocene and RuCl-
(dppe)(η5-C9H7) according to the procedure described for
complex 12 and purified by recrystallization from CH2Cl2-
MeOH. The title complex was obtained as red-orange crystals
Mp: 169 °C dec. IR (KBr): 1816 cm-1 1H NMR (400 MHz,
.
acetone-d6): δ 2.10 (s, 6H, CH3), 2.28 (s, 6H, CH3), 5.61 (s,
5H, η-C5H5 in Rc), 5.70 (s, 5H, η-C5H5), and 7.18-7.52 (m, 30H,
Ph). 13C NMR (100 MHz, acetone-d6): δ 11.58 (CH3), 90.32 (η-
C5H5), 97.95 (η-C5H5), 103.53 (η-C5Me4), 112.08 (η-C5Me4),
129.71 (t, J ) 5.1 Hz, m-Ph), 129.99 (ipso-C5Me4), 132.24 (p-
Ph), 134.17 (t, J ) 5.4 Hz, o-Ph), 135.04 (m, ipso-Ph), 172.67
(RuCCC), and 315.41 (t, J ) 15.2 Hz, RuCCC). 31P NMR (162
MHz, acetone-d6): δ 42.34. Anal. Calcd for C57H52B2F8P2Ru2‚1/
2CH2Cl2: C, 56.74; H, 4.39. Found: C, 56.53; H, 4.51.
[(η-C5H5)Ru(µ-η6:η1-C5Me4CdCd)Ru(dppe)(η-C5H5)](BF4)2
(19). This complex was prepared from 10 according to the
above procedure, yielding dark brown needles (81%). Mp: 180
°C dec. IR (KBr): 1825 cm-1. 1H NMR (400 MHz, acetone-d6):
δ 1.71 (s, 6H, CH3), 2.07 (s, 6H, CH3), 3.31 (m, 4H, PCH2),
4.90 (s, 5H, η-C5H5 in Rc), 6.04 (s, 5H, η-C5H5), and 7.39-7.87
(m, 20H, Ph). 13C NMR (100 MHz, acetone-d6): δ 11.19 (CH3),
1
(52 mg, 66%). Mp 232 °C. IR (KBr): 2070 cm-1 (ν(CtC)). H
NMR (CDCl3, 400 MHz): δ 2.09 (m, 2H, CH2), 2.48 (m, 2H,
CH2), 3.99 (t, J ) 1.6 Hz, â-C5H4), 4.11 (s, 5H, η-C5H5), 4.14
(t, J ) 1.6 Hz, R-C5H4), 4.99 (d, J ) 2.6 Hz, 1H, 1-C9H7), 5.18
(t, J ) 2.6 Hz, 1H, 2-C9H7), 6.89 (A2B2 type, 2H, 4-or 5-C9H7),
6.98 (A2B2 type, 2H, 4-or 5-C9H7), and 7.07-7.52 (m, 20H, Ph).
13C NMR (C6D6, 100 MHz): δ 28.30 (t, J ) 23.4 Hz, CH2), 68.69
(η-C5H4), 69.64 (1-C9H7), 70.71 (η-C5H5), 73.00 (η-C5H4), 79.65
(ipso-C5H4), 92.43 (2-C9H7), 104.64 (Ct), 106.65 (t, 2J CP ) 26.0
Hz, RuCt), 107.91 (ipso-C9H7), 123.76 (4 or 5-C9H7), 124.31
3
3
(4 or 5-C9H7), 127.60 (t, J CP ) 5.0 Hz, m-Ph), 127.84 (t, J CP
2
) 4.3 Hz, m-Ph), 128.99 (p-Ph), 129.48 (p-Ph), 132.30 (t, J CP
2
) 5.2 Hz, o-Ph), 134.45 (t, J CP ) 5.0 Hz, o-Ph), 136.91 (m,
ipso-Ph) and 141.68 (m, ipso-Ph). 31P NMR (162 MHz,